Drugs / VANILLYL ALCOHOL
VANILLYL ALCOHOL
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02357888 | Feb → May 2015 | nicotine dependence | Pierre Fabre Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT02359201 | Feb → Apr 2015 | — | Pierre Fabre Laboratories | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01574898 Comparator | Mar → Jun 2012 | — | Pierre Fabre Laboratories | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VANILLYL ALCOHOL | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297450 ↗ |
| Known as | FEMA NO. 3737 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297450 ↗ |
| Known as | NSC-3993 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297450 ↗ |
| Known as | V0018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01574898 ↗ |
| Known as | Vanillic alcohol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297450 ↗ |
| Modality | Small molecule | — CHEMBL4297450 ↗ |
| Route | Oral | “Single oral administration” NCT01574898 ↗ |